{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T17:34:38Z","timestamp":1791999278649,"version":"4.4.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lasers Med Sci"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Purpose. To compare perioperative and functional outcomes of standard holmium, Moses 1.0, and Moses 2.0 laser enucleation performed at an academic center with trainee involvement. Methods. We retrospectively reviewed men undergoing HoLEP between June 2022 and May 2024. Patients were grouped by laser platform: standard holmium, Moses 1.0, or Moses 2.0. Baseline demographics, perioperative data, complications, and functional outcomes up to six months were analyzed using analysis of variance or Kruskal\u2013Wallis tests. Results. Among 389 patients (standard holmium 206; Moses 1.0 126; Moses 2.0 57), baseline characteristics were similar. Median operative times were 95, 105, and 100 min for standard holmium, Moses 1.0, and Moses 2.0, respectively (p\u2009=\u20090.25), and median prostate weights were comparable (84 g, 85 g, 79 g; p\u2009=\u20090.44). Hospital stay was slightly longer with Moses lasers (1.6 vs. 1.4 days, p\u2009&lt;\u20090.001), though this difference is unlikely to be clinically significant. Objective measures of bleeding\u2014postoperative hemoglobin drop (1.7\u20132.0 g\/dL) and transfusion rates (0\u20131.6%)\u2014did not differ significantly between groups. Postoperative catheter duration, hospital stay, and complication rates were also comparable. Functional outcomes improved in all groups through 6 months, with no intergroup differences. Conclusion. HoLEP is safe and effective across conventional holmium, Moses 1.0, and Moses 2.0 platforms, with comparable perioperative and functional outcomes. Although the literature suggests that Moses 2.0 may facilitate same-day discharge, its absence should not limit HoLEP availability, and platform selection may reasonably reflect institutional resources and surgeon preference.<\/jats:p>","DOI":"10.1007\/s10103-026-04969-3","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:42:13Z","timestamp":1785285733000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Impact of pulse modulation technology on operating room time and blood loss in HoLEP: real-world data from an academic center"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1468-6085","authenticated-orcid":false,"given":"Juanita","family":"Velasquez-Ospina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabika","family":"Sadiq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ansh","family":"Bhatia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ha\u015fim","family":"Bakbak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Abdelaziz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gurpremjit","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Archan","family":"Khandekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Katz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Marcovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4273-5502","authenticated-orcid":false,"given":"Hemendra N.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,29]]},"reference":[{"key":"4969_CR1","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s40779-024-00569-w","volume":"11","author":"H Zi","year":"2024","unstructured":"Zi H, Liu M-Y, Luo L-S et al (2024) Global burden of benign prostatic hyperplasia, urinary tract infections, urolithiasis, bladder cancer, kidney cancer, and prostate cancer from 1990 to 2021. Military Med Res 11:64","journal-title":"Military Med Res"},{"key":"4969_CR2","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1007\/s11884-010-0067-2","volume":"5","author":"JK Parsons","year":"2010","unstructured":"Parsons JK (2010) Benign Prostatic Hyperplasia and Male Lower Urinary Tract Symptoms: Epidemiology and Risk Factors. Curr Bladder Dysfunct Rep 5:212\u2013218","journal-title":"Curr Bladder Dysfunct Rep"},{"key":"4969_CR3","doi-asserted-by":"publisher","first-page":"529","DOI":"10.21037\/tau.2019.10.01","volume":"8","author":"SD Lokeshwar","year":"2019","unstructured":"Lokeshwar SD, Harper BT, Webb E et al (2019) Epidemiology and treatment modalities for the management of benign prostatic hyperplasia. Transl Androl Urol 8:529\u2013539","journal-title":"Transl Androl Urol"},{"key":"4969_CR4","doi-asserted-by":"crossref","unstructured":"\u015awiniarski PP, St\u0119pie\u0144 S, Dudzic W et al (2012) 2012 BPH Thulium laser enucleation of the prostate (TmLEP) vs. transurethral resection of the prostate (TURP): evaluation of early results. cejurol3\/2012 65: 130\u2013134","DOI":"10.5173\/ceju.2012.03.art6"},{"key":"4969_CR5","doi-asserted-by":"crossref","unstructured":"S\u00e1nchez-Puy A, Bravo-Balado A, Diana P et al (2022) New Generation Pulse Modulation in Holmium:YAG Lasers: A Systematic Review of the Literature and Meta-Analysis. JCM ; 11: 3208","DOI":"10.3390\/jcm11113208"},{"key":"4969_CR6","first-page":"4828","volume":"11","author":"M Corrales","year":"2022","unstructured":"Corrales M, Sierra A, Traxer O (2022) Moses and Moses 2.0 for Laser Lithotripsy: Expectations vs. Real JCM 11:4828","journal-title":"Real JCM"},{"key":"4969_CR7","doi-asserted-by":"publisher","first-page":"S","DOI":"10.1089\/end.2020.0996","volume":"35","author":"CU Nottingham","year":"2021","unstructured":"Nottingham CU, Large T, Agarwal DK et al (2021) Comparison of Newly Optimized Moses Technology vs Standard Holmium:YAG for Endoscopic Laser Enucleation of the Prostate. J Endourol 35:S\u20131-7","journal-title":"J Endourol"},{"key":"4969_CR8","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1111\/bju.15265","volume":"127","author":"A Nevo","year":"2021","unstructured":"Nevo A, Faraj KS, Cheney SM et al (2021) Holmium laser enucleation of the prostate using Moses 2.0 vs non-Moses: a randomised controlled trial. BJU Int 127:553\u2013559","journal-title":"BJU Int"},{"key":"4969_CR9","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s00345-022-04205-x","volume":"41","author":"MR Socarr\u00e1s","year":"2022","unstructured":"Socarr\u00e1s MR, Del \u00c1lamo JF, Esp\u00f3sito F et al (2022) En Bloc enucleation with early apical release technique using MOSES (En Bloc MoLEP) vs. classic En Bloc HoLEP: a single arm study comparing intra- and postoperative outcomes. World J Urol 41:159\u2013165","journal-title":"World J Urol"},{"key":"4969_CR10","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/s00345-024-05277-7","volume":"42","author":"H Elmansy","year":"2024","unstructured":"Elmansy H, Boudreau R, Hodhod A et al (2024) Second-generation MOSES 2.0 versus MOSES 1.0 pulse-modulation technologies for holmium laser enucleation of the prostate (HoLEP). World J Urol 42:577","journal-title":"World J Urol"},{"key":"4969_CR11","doi-asserted-by":"publisher","unstructured":"Noureldin Y, Gupta A, Hodhod A et al (2022) Same-day trial of void and discharge following standard vs. MOSES holmium laser enucleation of the prostate: A single-center experience. CUAJ 17. https:\/\/doi.org\/10.5489\/cuaj.7983","DOI":"10.5489\/cuaj.7983"},{"key":"4969_CR12","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.urology.2024.03.008","volume":"189","author":"Z Tong","year":"2024","unstructured":"Tong Z, Sherryn S, Xia S et al (2024) MOSES\u2122 Technology vs Non-Moses Holmium Laser Enucleation of the Prostate: A Randomized Controlled Trial From a High-Volume Center. Urology 189:70\u201376","journal-title":"Urology"},{"key":"4969_CR13","doi-asserted-by":"publisher","first-page":"3005","DOI":"10.1007\/s00345-020-03535-y","volume":"39","author":"HN Shah","year":"2021","unstructured":"Shah HN, Etafy MH, Katz JE et al (2021) A randomized controlled trial comparing high and medium power settings for holmium laser enucleation of prostate. World J Urol 39:3005\u20133011","journal-title":"World J Urol"},{"key":"4969_CR14","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1007\/s00345-025-05621-5","volume":"43","author":"L Chen","year":"2025","unstructured":"Chen L, Chen C, Li C et al (2025) Low-power versus high-power laser for holmium laser enucleation of prostate: systematic review and meta-analysis. World J Urol 43:228","journal-title":"World J Urol"},{"key":"4969_CR15","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1097\/JU.0000000000001693","volume":"206","author":"NL Kavoussi","year":"2021","unstructured":"Kavoussi NL, Nimmagadda N, Robles J et al (2021) MOSES\u2122 Technology for Holmium Laser Enucleation of the Prostate: A Prospective Double-Blind Randomized Controlled Trial. J Urol 206:104\u2013108","journal-title":"J Urol"},{"key":"4969_CR16","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1007\/s00345-024-04830-8","volume":"42","author":"FO Hartung","year":"2024","unstructured":"Hartung FO, Egen L, Gruene B et al (2024) Pulse modulation in En-Bloc HoLEP: does it really matter? A propensity score matched analysis. World J Urol 42:154","journal-title":"World J Urol"},{"key":"4969_CR17","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.urology.2019.11.029","volume":"136","author":"T Large","year":"2020","unstructured":"Large T, Nottingham C, Stoughton C et al (2020) Comparative Study of Holmium Laser Enucleation of the Prostate With MOSES Enabled Pulsed Laser Modulation. Urology 136:196\u2013201","journal-title":"Urology"},{"key":"4969_CR18","doi-asserted-by":"publisher","first-page":"S83","DOI":"10.1016\/S2666-1683(20)35437-9","volume":"20","author":"YH Mohamed Ismail","year":"2020","unstructured":"Mohamed Ismail YH, Petrelli F, Ceresoli F et al (2020) MoLEP is better than HoLEP, evidence from the first prospective randomized study involving 140 patients. Eur Urol Open Sci 20:S83\u2013S84","journal-title":"Eur Urol Open Sci"},{"key":"4969_CR19","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1111\/bju.16447","volume":"134","author":"S Kutchukian","year":"2024","unstructured":"Kutchukian S, Chicaud M, Berthe L et al (2024) Comparison of holmium:yttrium-aluminium-garnet (YAG), thulium fiber laser, and pulsed thulium:YAG lasers on soft tissue: an ex vivo study. BJU Int 134:763\u2013772","journal-title":"BJU Int"},{"key":"4969_CR20","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1177\/1756287211400494","volume":"3","author":"A Zarrabi","year":"2011","unstructured":"Zarrabi A, Gross AJ (2011) The evolution of lasers in urology. Ther Adv Urol 3:81\u201389","journal-title":"Ther Adv Urol"},{"key":"4969_CR21","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1007\/s00345-023-04617-3","volume":"41","author":"HN Shah","year":"2023","unstructured":"Shah HN, Arbelaez MCS, Shah K et al (2023) Histopathological assessment of depth of coagulation necrosis with Holmium, Moses, and Thulium fiber lasers in human prostate tissue. World J Urol 41:3059\u20133063","journal-title":"World J Urol"},{"key":"4969_CR22","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1089\/end.2020.1218","volume":"35","author":"MA Assmus","year":"2021","unstructured":"Assmus MA, Large T, Lee MS et al (2021) Same-Day Discharge Following Holmium Laser Enucleation in Patients Assessed to Have Large Gland Prostates (\u2265\u2009175\u00a0cc). J Endourol 35:1386\u20131392","journal-title":"J Endourol"},{"key":"4969_CR23","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1016\/j.euf.2022.01.013","volume":"8","author":"V Gauhar","year":"2022","unstructured":"Gauhar V, Gilling P, Pirola GM et al (2022) Does MOSES Technology Enhance the Efficiency and Outcomes of Standard Holmium Laser Enucleation of the Prostate? Results of a Systematic Review and Meta-analysis of Comparative Studies. Eur Urol Focus 8:1362\u20131369","journal-title":"Eur Urol Focus"},{"key":"4969_CR24","doi-asserted-by":"publisher","unstructured":"Ramadhani MZ, Kloping YP, Rahman IA et al (2022) Comparative efficacy and safety of holmium laser enucleation of the prostate (HoLEP) using moses technology and standard HoLEP: A systematic review, meta-analysis, and meta-regression. Annals Med Surg 81. https:\/\/doi.org\/10.1016\/j.amsu.2022.104280","DOI":"10.1016\/j.amsu.2022.104280"},{"key":"4969_CR25","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.1007\/s00345-022-04174-1","volume":"40","author":"M Hout","year":"2022","unstructured":"Hout M, Gurayah A, Arbelaez MCS et al (2022) Incidence and risk factors for postoperative urinary incontinence after various prostate enucleation procedures: systemic review and meta-analysis of PubMed literature from 2000 to 2021. World J Urol 40:2731\u20132745","journal-title":"World J Urol"},{"key":"4969_CR26","doi-asserted-by":"publisher","first-page":"88","DOI":"10.5534\/wjmh.2015.33.2.88","volume":"33","author":"JK Nam","year":"2015","unstructured":"Nam JK, Kim HW, Lee DH et al (2015) Risk Factors for Transient Urinary Incontinence after Holmium Laser Enucleation of the Prostate. World J Mens Health 33:88","journal-title":"World J Mens Health"}],"container-title":["Lasers in Medical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10103-026-04969-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10103-026-04969-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10103-026-04969-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T17:32:24Z","timestamp":1785519144000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10103-026-04969-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,29]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4969"],"URL":"https:\/\/doi.org\/10.1007\/s10103-026-04969-3","relation":{},"ISSN":["1435-604X"],"issn-type":[{"value":"1435-604X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,29]]},"assertion":[{"value":"30 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"IRB approval was obtained (IRB# 20180511) and all study procedures followed institutional and international ethical standards.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was granted exemption from informed consent.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"170"}}